UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
H H+ H1 HA HB HC HD HE HF HG HH HI HK HL HM HN HO HP HQ HR HS HT HU HV HX HY HZ
selected terms: 2,761 page 24 of 28

2301. HX-PROSTATIC MALIGNANCY
[ ] (UMLS (ICD9CM) C0260429) =Finding
2351. Hycorace
(UMLS (NCI) C0701089) =Steroid; Pharmacologic Substance ;
2302. HX-RECTAL & ANAL MALIGN
[ ] (UMLS (ICD9CM) C0260411) =Finding
2352. Hydaburg Cooperative Association
(UMLS (HL7) C1550874) =Population Group =NativeEntityAlaska;
2303. HX-RESP ORG MALIGNAN NOS
[ ] (UMLS (ICD9CM) C0260418) =Finding
2353. hydantoin
[group of anticonvulsants containing an allantoin heterocyclic base. ( CSP )] (UMLS (CSP) C0020209) =Organic Chemical; Pharmacologic Substance =imidazole;
imidazoledione =dantrolene;
5,5-Diphenyl-2,4-imidazolidinedione;
allantoin;
dantrolene;
3-ethyl-5-phenyl-2,4-imidazolidinedione;
MEPHENYTOIN;
5,5-Diphenyl-2,4-imidazolidinedione;
1,3-dimethylol-5,5-dimethylhydantoin
2304. HX-SKIN MALIGNANCY NEC
[ ] (UMLS (ICD9CM) C0260449) =Finding
2354. Hydatid Mole
[trophoblastic hyperplasia associated with normal gestation, or molar pregnancy; characterized by the swelling of the chorionic villi and elevated human chorionic gonadotropin; hydatidiform moles or molar pregnancy may be categorized as complete or partial based on their gross morphology, histopathology, and karyotype. ( CSP )] (UMLS (NCI) C0020217) =Neoplastic Process ;
=female reproductive system cancer;
Trophoblastic Neoplasm;
Pregnancy Disorder;
=Chorioadenoma;
2305. HX-SKIN/SUBCUTAN TIS DIS
[ ] (UMLS (ICD9CM) C0260476) =Finding
2355. Hydeltra
(UMLS (NCI) C0702183) =Steroid; Pharmacologic Substance
2306. HX-SULFONAMIDES ALLERGY
[ ] (UMLS (ICD9CM) C0260486) =Finding
2356. Hydra
[A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals. ( MSH )] (UMLS (CSP) C0020222) =Invertebrate ;
2307. HX-TESTICULAR MALIGNANCY
[ ] (UMLS (ICD9CM) C0260430) =Finding
2357. hydralazine/IFN-A
(UMLS (NCI) C0338171) =Therapeutic or Preventive Procedure
2308. HX-THROMBOPHLEBITIS
[ ] (UMLS (ICD9CM) C0375801) =Finding
2358. hydration
[Combining with water. ( NCI )] (UMLS (NCI) C1321013) =Finding
2309. HX-TRACHEAL MALIGNANCY
[ ] (UMLS (ICD9CM) C0260416) =Finding
2359. hydrazine
[colorless, gaseous diamine, H2N-NH2, or its substitution derivatives. ( CSP )] (UMLS (CSP) C0020233) =Organic Chemical ;
=azo compound;
Organic Chemical =1(2H)-Phthalazinone Hydrazone;
INH;
methylhydrazine;
PHENELZINE;
phenylhydrazine;
Benzethyzin;
(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic Acid;
INH;
PHENELZINE;
2310. HX-TROPHOBLASTIC DISEASE
[ ] (UMLS (ICD9CM) C0260474) =Finding
2360. Hydrazine Sulfate
[A substance that has been studied as a treatment for cancer and as a treatment for cachexia (body wasting) associated with advanced cancer. ( NCI )] (UMLS (NCI) C0063067) =Inorganic Chemical
2311. HX-URINARY MALIGNAN NEC
[ ] (UMLS (ICD9CM) C0260436) =Finding
2361. hydrazone
[compound formed from an aldehyde or ketone by the action of phenylhydrazine. ( CSP )] (UMLS (CSP) C0020235) =Organic Chemical ;
=azo compound;
=1,1'-[(methylethanediylidene)dinitrilo)diguanidine;
thiosemicarbazone
2312. HX-URINARY MALIGNAN NOS
[ ] (UMLS (ICD9CM) C0260433) =Finding
2362. Hydrea
(UMLS (NCI) C0591617) =Organic Chemical; Pharmacologic Substance ;
2313. HX-UTERUS MALIGNANCY NEC
[ ] (UMLS (ICD9CM) C0260425) =Finding
2363. hydrocarbon
[organic compound that contains carbon and hydrogen only. ( CSP )] (UMLS (CSP) C0020242) =Organic Chemical ;
=Organic Chemical;
=alkane;
alkene;
alkyne;
lipid;
Hydrocarbons, Acyclic;
Hydrocarbons, Cyclic;
Halogenated Hydrocarbon;
Paraffin;
petrolatum;
terpene
2314. HX-VACCINE ALLERGY
[ ] (UMLS (ICD9CM) C0260491) =Finding
2364. hydrocarbon oxidoreductase
[ ] (UMLS (CSP) C0596733) =Amino Acid, Peptide, or Protein; Enzyme =dehydrogenase;
=fumarate hydrogenase;
3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2;
acyl coA dehydrogenase;
2315. HX-VEN THROMBOSIS/EMBOLS
[ ] (UMLS (ICD9CM) C0375800) =Finding
2365. HYDROCELE CANAL NUCK-FEM
[ ] (UMLS (ICD9CM) C0156420) =Anatomical Abnormality
2316. HY antigen
[sex-specific cell surface antigen produced by the sex-determining gene of the Y chromosome in mammals; causes syngeneic grafts from males to females to be rejected and interacts with somatic elements of the embryologic undifferentiated gonad to produce testicular organogenesis. ( CSP )] (UMLS (CSP) C0018449) =Immunologic Factor ;
=histocompatibility antigen;
2366. HYDROCELE NEC
[ ] (UMLS (ICD9CM) C0029837) =Disease or Syndrome; Anatomical Abnormality
2317. HY HT/KD NOS I-IV W/O HF
[ ] (UMLS (ICD9CM) C0155612) =Disease or Syndrome
2367. HYDROCEPH FETUS-ANTEPART
[ ] (UMLS (ICD9CM) C0156991) =Disease or Syndrome ;
2318. HY HT/KD NOS ST V W/O HF
[ ] (UMLS (ICD9CM) C0348879) =Disease or Syndrome
2368. HYDROCEPH FETUS-DELIVER
[ ] (UMLS (ICD9CM) C0156990) =Disease or Syndrome ;
2319. HY KID NOS W CR KID I-IV
[ ] (UMLS (ICD9CM) C0494574) =Disease or Syndrome ;
2369. HYDROCEPHAL FETUS-UNSPEC
[ ] (UMLS (ICD9CM) C0156989) =Disease or Syndrome ;
2320. hyalin
[clear, homogenous, structureless, eosinophilic substance occurring in pathological degeneration of tissues. ( CSP )] (UMLS (CSP) C0020191) =Body Substance =extracellular;
2370. Hydrocephalic fetus causing disproportion
[ ] (UMLS (ICD9CM) C0156988) =Finding ;
2321. Hyaline Cartilage
[Cartilage (tissue) which consists of chondrocytes and collagen, the intercellular matrix of which is an amorphous gel with a perichondrium. ( UWDA )] (UMLS (NCI) C0225362) =Tissue
2371. hydrocephalus
[excessive accumulation of cerebrospinal fluid within the cranium which may be a congenital or acquired disorder; hydrocephalus ex-vacuo refers to ventricular dilation that occurs as a result of brain substance loss from cerebral infarction and other conditions. ( CSP )] (UMLS (NCI) C0020255) =Disease or Syndrome =Infant, Newborn, Diseases;
Intracranial Hypertension;
CEREB DEGENERATION NOS;
congenital brain disorder =Dandy-Walker Syndrome;
Hydrocephalus, Normal Pressure;
2322. Hyaline Cast Formation
(UMLS (NCI) C0333121) =Finding ;
2372. HYDROCODONE
[A semisynthetic hydrogenated codeine derivative and opioid agonist with analgesic and antitussive effects. Hydrocodone primarily binds to and activates the mu-opioid receptor in the central nervous system (CNS). This leads to analgesia, euphoria, respiratory depression, miosis, decreased gastrointestinal motility, cough suppression and physical dependence. Hydrocodone is converted to hydromorphone by the cytochrome P450 enzyme CYP2D6. ( NCI )] (UMLS (NCI) C0020264) =Organic Chemical; Pharmacologic Substance ;
=[CN101] OPIOID ANALGESICS;
codeine;
[RE301] OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS;
=HYDROCODONE BITARTRATE;
HYDROCODONE POLISTIREX;
HYDROCODONE RESIN COMPLEX;
HYDROCODONE BITARTRATE;
HYDROCODONE POLISTIREX;
HYDROCODONE RESIN COMPLEX;
Hydrocodone 1 MG/ML;
HYDROCODONE 10 MG;
HYDROCODONE 7.5 MG;
HYDROCODONE 5 MG;
2323. hyaline membrane disease
[A disorder affecting newborn infants (usually premature) characterized pathologically by the development of a hyaline-like membrane lining the terminal respiratory passages. Extensive atelectasis is attributed to the lack of surfactant. (Dorland, 27th ed) ( MSH )] (UMLS (CSP) C0020192) =Disease or Syndrome =RDS;
2373. Hydrocodone/Acetaminophen
[A combination preparation of the analgesic acetaminophen and the semisynthetic opioid agonist hydrocodone with analgesic and antitussive activities. Acetaminophen exerts its analgesic activity by inhibiting prostaglandin synthesis while hydrocodone exerts its analgesic activity by binding to the mu-receptors in the central nervous system (CNS), thereby mimicking the effects of endogenous opioids. ( NCI )] (UMLS (NCI) C0717367) =Organic Chemical; Pharmacologic Substance ;
2324. Hyaline Membrane Syndrome
(UMLS (NCI) C1334061) =Congenital Abnormality; Disease or Syndrome
2374. HYDROCORTAMATE
(UMLS (NCI) C0544368) =Steroid; Pharmacologic Substance; Hormone
2325. Hyalinized Stroma Formation
(UMLS (NCI) C1334062) =Finding ;
2375. HYDROCORTAMATE HYDROCHLORIDE
(UMLS (NCI) C1445700) =Steroid; Pharmacologic Substance; Hormone
2326. Hyalinizing Trabecular Adenoma of the Thyroid
[A rare, circumscribed or encapsulated tumor arising from the follicular cells of the thyroid gland. It is characterized by a trabecular growth pattern and hyalinized stroma formation. The vast majority of cases have a benign clinical course. ( NCI )] (UMLS (NCI) C1336751) Hyalinizing Trabecular Adenoma of Thyroid;
Hyalinizing Trabecular Tumor;
Paraganglioma-like Adenoma;
PLAT;
Thyroid Gland Hyalinizing Trabecular Tumor;
Thyroid Hyalinizing Trabecular Adenoma =Neoplastic Process ;
2376. HYDROCORTISONE ACETATE
[The synthetic acetate salt form of hydrocortisone, a corticosteroid with anti-inflammatory and immunosuppressive properties. Hydrocortisone acetate initially binds to the cytoplasmic glucocorticoid receptor; then the receptor-ligand complex is translocated to the nucleus where it initiates the transcription of genes encoding for anti-inflammatory mediators, such as cytokines and lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes. ( NCI )] (UMLS (NCI) C0063077) =Steroid; Pharmacologic Substance ;
=(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione;
[OR900] DENTAL AND ORAL AGENTS, TOPICAL OTHER;
[OP300] ANTI-INFLAMMATORIES, TOPICAL OPHTHALMIC;
=HYDROCORTISONE ACETATE 0.5 %;
HYDROCORTISONE ACETATE 1 %WV;
HYDROCORTISONE ACETATE 10 MG;
HYDROCORTISONE ACETATE 10 MG/GM;
HYDROCORTISONE ACETATE 25 GM;
HYDROCORTISONE ACETATE 5 MG;
HYDROCORTISONE ACETATE 50 MG/ML;
HYDROCORTISONE ACETATE 25 MG;
HYDROCORTISONE ACETATE 10 %;
HYDROCORTISONE ACETATE 30 MG;
HYDROCORTISONE ACETATE 25 MG/ML;
HYDROCORTISONE ACETATE 15 MG;
HYDROCORTISONE ACETATE 2.5 %;
HYDROCORTISONE ACETATE 1 %;
2327. Hyalitis
[Inflammatory intraocular reaction with clouding and cells in vitreous; often accompanies inflammation of ciliary body, iris, choroid, or retina. ( NCI )] (UMLS (NCI) C0235812) =Disease or Syndrome
2377. Hydrocortisone Cypionate
(UMLS (NCI) C0612688) =Steroid; Pharmacologic Substance ;
=(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione;
=HYDROCORTISONE CYPIONATE 10 MG/5ML
2328. hyaluronan
[ ] (UMLS (CSP) C0813622) =Carbohydrate; Pharmacologic Substance; Biologically Active Substance
2378. Hydrocortisone Sodium Phosphate
(UMLS (NCI) C0770559) HYDROCORTISONE SODIUM PHOSPHATE PREPARATION;
=Steroid; Pharmacologic Substance ;
=(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione;
=HYDROCORTISONE SODIUM PHOSPHATE 50 MG/ML;
2329. hyaluronan synthetase
[ ] (UMLS (CSP) C0063046) =Amino Acid, Peptide, or Protein; Enzyme ;
2379. Hydrocortisone Used as a Placebo
[Hydrocortisone used as a placebo in comparative studies. ( NCI )] (UMLS (NCI) C0281715) =Therapeutic or Preventive Procedure
2330. Hyaluronate
[The sodium salt form of hyaluronic acid, a glucosaminoglycan, a component of connective tissue, skin, vitreous humour, umbilical cord, synovial fluid and the capsule of certain microorganisms contributing to adhesion, elasticity, and viscosity of extracellular substances. ( NCI )] (UMLS (NCI) C0087000) =Carbohydrate; Pharmacologic Substance; Biologically Active Substance =HYALURONATE;
=AQUA-A CREAM;
AQUADERM CREAM;
AQUADERM LOTION;
HYALURONATE SODIUM 14 MG/ML;
HYALURONATE SODIUM 30 MG/ML;
HYALURONATE SODIUM 10 MG/ML;
HYALURONATE SODIUM 16 MG/ML;
DUOVISC,KIT 0.35ML/0.4ML INJ,OPH;
DUOVISC,KIT 0.5ML/0.55ML INJ,OPH;
GELCLAIR,GEL,ORAL,PKT,15ML;
HYALURONATE SODIUM 12 MG/ML;
2380. Hydrocortisone/Ketoconazole
(UMLS (NCI) C0935705) =Therapeutic or Preventive Procedure
2331. hyaluronate lyase
[ ] (UMLS (CSP) C0063043) =Amino Acid, Peptide, or Protein; Enzyme ;
2381. Hydrodiuril
(UMLS (NCI) C0700698) =Organic Chemical; Pharmacologic Substance ;
2332. Hyaluronic Acid
[A glucosaminoglycan consisting of D-glucuronic acid and N-acetyl-D-glucosamine disaccharide units that is a component of connective tissue, skin, vitreous humour, umbilical cord, synovial fluid and the capsule of certain microorganisms contributing to adhesion, elasticity, and viscosity of extracellular substances. ( NCI )] (UMLS (NCI) C0020196) =Carbohydrate; Pharmacologic Substance; Biologically Active Substance =gag(glycosaminoglycan);
[MS109] ANTIRHEUMATICS, OTHER;
[OP900] OPHTHALMICS, OTHER;
=hylan;
HYALURONATE;
COLLADERM GEL,TOP;
2382. hydrofluoric acid
[Hydrofluoric acid. A solution of hydrogen fluoride in water. It is a colorless fuming liquid which can cause painful burns. ( MSH )] (UMLS (CSP) C0020274) =Hazardous or Poisonous Substance; Inorganic Chemical ;
=Acids, Noncarboxylic;
Fluorine Compounds;
Inactive Ingredient Preparations;
=[TN407] FLUORIDE;
HYDROFLUORIC ACID 42.6 MG;
HYDROFLUORIC ACID 7.1 MG;
HYDROFLUORIC ACID 729 MG;
HYDROFLUORIC ACID 0.17 %;
HYDROFLUORIC ACID 0.2 %;
HYDROFLUORIC ACID 0.28 %
2333. Hyaluronic Acid Binding
[Hyaluronic Acid Binding involves a biophysical interaction between a biological molecule, such as a protein, and hyaluronic acid, a linear glycosaminoglycan of repeating disaccharide units, in proteoglycans. ( NCI )] (UMLS (NCI) C1148609) =Molecular Function ;
2383. hydrogel lenticular implantation
[ ] (UMLS (CSP) C0599292) =Therapeutic or Preventive Procedure
2334. Hyaluronidase PH-20
[Hyaluronidase degrades hyaluronic acid, a major structural proteoglycan found in extracellular matrices and basement membranes. Six members of the hyaluronidase family are clustered into two tightly linked groups on chromosome 3p21.3 and 7q31.3. This gene encodes a GPI-anchored enzyme located on the human sperm surface and inner acrosomal membrane. This multifunctional protein is a hyaluronidase that enables sperm to penetrate through the hyaluronic acid-rich cumulus cell layer surrounding the oocyte, a receptor that plays a role in hyaluronic acid induced cell signaling, and a receptor that is involved in sperm-zona pellucida adhesion. Abnormal expression of this gene in tumors has implicated this protein in degradation of basement membranes leading to tumor invasion and metastasis. (from LocusLink) ( NCI )] (UMLS (NCI) C0083996) =Amino Acid, Peptide, or Protein; Biologically Active Substance
2384. hydrogen bond
[strong intermolecular forces produced by the attraction of a hydrogen atom, already covalently bonded to one electronegative atom, to a second electronegative atom of the same molecule or an adjacent molecule; these bonds are found in compounds containing strong electronegative atoms such as fluorine, oxygen, or nitrogen. ( CSP )] (UMLS (CSP) C0020276) =Natural Phenomenon or Process =chemical bond;
2335. Hyamptin
[ ] (UMLS (CSP) C0599552) =Pharmacologic Substance ;
2385. hydrogen channel
[molecule-sized pores in biomembranes that permit the passage of hydrogen ions, and the proteins that form such pores and control their permeability; especially, a passage in the inner mitochondrial membrane that facilitates the movement of protons out of the mitochondrial matrix during oxidative phosphorylation. ( CSP )] (UMLS (CSP) C0596734) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Ion Channel;
2336. hybrid
[ ] (UMLS (CSP) C0007597) =Laboratory Procedure =tissue/cell culture;
=hybridoma;
heterokaryon;
◊ [ ] (UMLS (CSP) C0020205) Organism
2386. hydrogen electrode
[ ] (UMLS (CSP) C0598355) =Manufactured Object ;
2337. hybrid antibody
[ ] (UMLS (CSP) C0596731) =Amino Acid, Peptide, or Protein; Immunologic Factor =Ab;
Immunologic Factors;
Chimera Protein;
2387. hydrogen fluoride
[ ] (UMLS (CSP) C0520465) =Hazardous or Poisonous Substance; Inorganic Chemical ;
2338. hybrid enzyme
[ ] (UMLS (CSP) C0596732) =Amino Acid, Peptide, or Protein; Enzyme =enzyme;
Chimera Protein
2388. hydrogen peroxide generating oxidase
[nonEC. ( CSP )] (UMLS (CSP) C0897757) oxygen generating oxidase;
oxygen producing enzyme;
respiratory burst oxidase;
superoxide forming enzyme =Amino Acid, Peptide, or Protein; Enzyme ;
=NAD(P)H oxidoreductase;
2339. hybrid gene
[ ] (UMLS (CSP) C0598468) =Gene or Genome
2389. hydrogen sulfide
[toxic gas, H2S. ( CSP )] (UMLS (CSP) C0020282) =Indicator, Reagent, or Diagnostic Aid; Hazardous or Poisonous Substance; Inorganic Chemical =Acids, Noncarboxylic;
Gas;
sulfide;
sulfur compound =sulfide
2340. hybrid nuclease
[ ] (UMLS (CSP) C0599356) =Amino Acid, Peptide, or Protein; Enzyme
2390. hydrogen transport
[movement of hydrogen ions (protons) across biological membranes; may be active, passive, or facilitated. ( CSP )] (UMLS (CSP) C0596735) =Cell Function ;
=biological transport;
2341. Hybrid Odontogenic Fibroma
(UMLS (NCI) C1334063) =Neoplastic Process ;
2391. hydrogenase
[specific enzyme (EC 1.18.99.1) that catalyzes the conversion of H+ to hydrogen gas via oxidation of ferredoxin; do not use for general term to cover other hydrogenating enzymes. ( CSP )] (UMLS (CSP) C0020284) =Amino Acid, Peptide, or Protein; Enzyme ;
=miscellaneous oxidoreductase;
2342. hybrid protein
[ ] (UMLS (CSP) C0598148) =Amino Acid, Peptide, or Protein ;
2392. hydrogenation
[Addition of hydrogen to a compound, especially to an unsaturated fat or fatty acid. (From Stedman, 26th ed) ( MSH )] (UMLS (CSP) C0020286) =Natural Phenomenon or Process
2343. Hybrid Resistance
(UMLS (NCI) C1369008) =Disease or Syndrome
2393. hydrolase
[Enzymes (EC class 3) cleaving substrates with addition of H2O at the point of cleavage; e.g., esterases, phosphatases, nucleases, peptidases. SYN hydrolyzing enzymes. ( NCI )] (UMLS (CSP) C0020289) =Amino Acid, Peptide, or Protein; Enzyme ;
=enzyme;
Enzymatic Agents =Ester Hydrolase;
glycosidase;
Enzymes, Proteolytic;
acid anhydride hydrolase;
carbon carbon hydrolase;
carbon nitrogen hydrolase;
ether hydrolase;
hepatic lipase;
amidinohydrolase;
aminohydrolase;
Ester Hydrolase;
glycosidase;
Pancreatin;
Enzymes, Proteolytic
2344. Hybridization
[zipping reaction between complementary DNA or RNA single strands to form a duplex (double stranded) molecule; basis of many techniques for assaying nucleic acid sequence complementarity. ( CSP )] (UMLS (NCI) C0028602) =Natural Phenomenon or Process ;
=genetic technique;
=Blotting, Northern;
Blotting, Southern;
nucleic acid denaturation;
nucleic acid probe;
Genetics, in situ Hybridization;
nucleic acid reconstitution;
subtraction hybridization;
liquid hybridization;
2394. Hydrolase Family Gene
(UMLS (NCI) C1334064) Hydrolase Gene =Gene or Genome ;
2345. Hybridization Protection Assay
[Molecular, Hybridization Protection Assay ( HL7V3.0 )] (UMLS (HL7) C1553157) =Laboratory Procedure =ObservationMethod;
2395. hydrolysis
[process of cleaving a chemical compound by the addition of a molecule of water. ( CSP )] (UMLS (NCI) C0020291) =Natural Phenomenon or Process =solvolysis;
2346. hybridoma
[cells artificially created by fusion of activated lymphocytes with neoplastic cells; the resulting hybrid cells are cloned and produce pure or monoclonal antibodies or T-cell products, identical to those produced by the immunologically competent parent, and continually grow and divide as the neoplastic parent. ( CSP )] (UMLS (CSP) C0020204) =Cell =hybrid;
Cell Clone
2396. HYDROMYELIA
(UMLS (ICD9CM) C0152444) =Congenital Abnormality
2347. hybridoma production
[ ] (UMLS (CSP) C1328908) =Laboratory Procedure
2397. hydronaphthalene
[ ] (UMLS (CSP) C0596736) =Organic Chemical ;
2348. HYC
[A thioxanthene derivative of lucanthone with anti-schistosomal activity and potential antineoplastic activity. Hycanthone interferes with parasite nerve function, resulting in parasite paralysis and death. This agent also intercalates into DNA and inhibits RNA synthesis in vitro. (NCI04) ( NCI )] (UMLS (NCI) C0020207) =Organic Chemical; Pharmacologic Substance ;
2398. hydronaphthylamine
[ ] (UMLS (CSP) C0598920) =Organic Chemical ;
2349. Hycamtin
(UMLS (NCI) C0700915) =Organic Chemical; Pharmacologic Substance
2399. hydronephrosis
[distention of the pelvis and calices of the kidney with urine, as a result of obstruction of the ureter, with accompanying atrophy of the parenchyma of the organ. ( CSP )] (UMLS (NCI) C0020295) =Disease or Syndrome =Kidney Disease;
2350. Hycanthone Mesylate
(UMLS (NCI) C0063050) =Organic Chemical; Pharmacologic Substance ;
2400. hydropathy
[tendency of a chemical compound or molecular domain to be included (hydrophilicity) or excluded (hydrophobicity) from aqueous solvents; important in protein folding, structure, and binding and biological membrane structure; do not use for hydrotherapy. ( CSP )] (UMLS (CSP) C0596737) =Quantitative Concept ;
=Chemical Properties;

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.

 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM